Hemin
Generic name: Hemin
Brand names: Panhematin
Dosage form: intravenous powder for injection (350 mg)
Drug class:
Miscellaneous uncategorized agents
Usage of Hemin
Hemin is made of red blood cells processed from human blood. Hemin works by lowering the production of a certain enzyme in the body.
Hemin is used to treat the symptoms of occasional attacks of porphyria related to the menstrual cycle in women. Hemin helps control symptoms such as pain, increased heart rate or blood pressure, and changes in mental status.
Hemin should not be used to treat porphyria that affects the skin, also called porphyria cUTAnea tarda.
Hemin is not a cure for porphyria. It will only control the symptoms of a porphyria episode.
Hemin may also be used for purposes not listed in this medication guide.
Hemin side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Hemin may cause serious side effects. Stop using hemin and call your doctor at once if you have:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Hemin
You should not use hemin if you are allergic to it.
To make sure hemin is safe for you, tell your doctor if you have:
Hemin is made from human plasma (part of the blood) which may contain viruses and other infectious agents. Donated plasma is tested and treated to reduce the risk of it containing infectious agents, but there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.
It is not known whether hemin will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
It is not known whether hemin passes into breast milk or if it could affect a nursing baby. Tell your doctor if you are breast-feeding a baby.
Hemin is not approved for use by anyone younger than 16 years old.
Relate drugs
- Absorica
- Absorica LD
- Adakveo
- Aminohippurate sodium
- Ammonul
- Amondys 45
- Amphadase
- Amphadase injection
- Collagenase clostridium histolyticum
- Collagenase clostridium histolyticum-aaes
- Crizanlizumab
- Crizanlizumab-tmca
- Cystagon
- Cysteamine
- Cysteamine (Oral)
- Betibeglogene autotemcel
- Carbaglu
- Carglumic acid
- Casimersen
- Chlorophyllin
- Chymopapain
- Daprodustat
- Delandistrogene moxeparvovec-rokl
- Deoxycholic acid
- Derifil
- Dexrazoxane
- Dextranomer and sodium hyaluronate
- Elevidys
- Elivaldogene autotemcel
- Esbriet
- Eteplirsen
- Etranacogene dezaparvovec-drlb
- Evrysdi
- Exondys 51
- Fecal microbiota, live-jslm
- Golodirsen
- Hemgenix
- Hemin
- Hyaluronidase
- Hyaluronidase injection
- Hydase
- Hylenex
- Hylenex injection
- Jesduvroq
- Kepivance
- Kinevac
- Kybella
- Methacholine
- Nusinersen
- Nusinersen injection
- Omidubicel-onlv
- Omisirge
- Onasemnogene abeparvovec Zolgensma
- Onasemnogene abeparvovec-xioi
- Oxbryta
- Palifermin
- Palovarotene
- Panhematin
- Pirfenidone
- Plasminogen human
- Plasminogen, human-tvmh
- Procysbi
- Protirelin
- Provocholine
- Qwo
- Rebyota
- Risdiplam
- Ryplazim
- Sclerosol Intrapleural
- Sculptra
- Sincalide
- Skysona
- Sodium phenylacetate and benzoate
- Sohonos
- Spinraza
- Steritalc
- Talc
- Thyrel TRH
- Totect
- Viltepso
- Viltolarsen
- Vitrase
- Voxelotor
- Vyondys 53
- Xiaflex
- Zenatane
- Zinecard
- Zolgensma
- Zynteglo
How to use Hemin
Usual Adult Dose for Porphyria:
1 to 4 mg/kg/day IV over at least 30 minutes for 3 to 14 days based on clinical signs; in more severe cases, this dose may be repeated no earlier than every 12 hours-Maximum dose: 6 mg/kg per 24 hoursUses: -This drug is indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women; pain, hypertension, tachycardia, abnormal mental status, and mild to progressive neurologic signs may be controlled in patients with this disorder-Similar findings have been reported in other patients with acute intermittent porphyria, porphyria variegata, and hereditary coproporphyria (this drug is not indicated in porphyria cutanea tarda)
Usual Pediatric Dose for Porphyria:
16 years and older:1 to 4 mg/kg/day IV over at least 30 minutes for 3 to 14 days based on clinical signs; in more severe cases, this dose may be repeated no earlier than every 12 hours-Maximum dose: 6 mg/kg per 24 hoursUses: -This drug is indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women; pain, hypertension, tachycardia, abnormal mental status, and mild to progressive neurologic signs may be controlled in patients with this disorder-Similar findings have been reported in other patients with acute intermittent porphyria, porphyria variegata, and hereditary coproporphyria (this drug is not indicated in porphyria cutanea tarda)
Warnings
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
What other drugs will affect Hemin
Tell your doctor about all your current medicines and any you start or stop using, especially:
This list is not complete. Other drugs may interact with hemin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions